Novota P, Cerná M, Andĕl M
CBO-oddĕlení bunĕcné a molekulární biologie 3. LF UK, Praha.
Cas Lek Cesk. 2002 Mar 29;141(6):171-5.
The HLA complex is the most polymorphic genetic system in man yet known. The variability of the HLA antigens is given by the presence of many alleles of the HLA genes. Requirements for compatibility of HLA antigens in organ and bone marrow transplantations, and also in the determination of genetic risk factors in autoimmune diseases evoke strong pressure on progress in HLA typing methods, mainly for increasing their sensitivity and resolution. For typing of the HLA antigens there are used cellular, serological, biochemical and DNA methods. For HLA class I typing there following tests are used: cytotoxic test (serological), CML (cellular), 1D--IEF (biochemical), RFLP, SSO, SSP--PCR, and SBT (DNA methods). For HLA class II typing, cytotoxic test (cellular), MLC (serological), RFLP, SSO, SSP--PCR, and SBT (DNA methods) are used. DNA methods represent the modern trend in the area of HLA typing and it will probably replace larger part of other HLA typing techniques. In our article, we describe the principles of methods that are used for HLA typing.
HLA复合体是迄今所知人类中多态性最高的遗传系统。HLA抗原的变异性源于HLA基因存在众多等位基因。器官和骨髓移植中对HLA抗原相容性的要求,以及自身免疫性疾病中遗传风险因素的判定,都对HLA分型方法的进展产生了强大的推动作用,主要是为了提高其灵敏度和分辨率。HLA抗原分型采用细胞、血清学、生化和DNA方法。HLAⅠ类分型采用以下检测方法:细胞毒性试验(血清学方法)、混合淋巴细胞培养(细胞方法)、一维等电聚焦(生化方法)、限制性片段长度多态性分析、序列特异性寡核苷酸探针杂交、序列特异性引物聚合酶链反应以及序列分型(DNA方法)。HLAⅡ类分型采用细胞毒性试验(细胞方法)、混合淋巴细胞反应(血清学方法)、限制性片段长度多态性分析、序列特异性寡核苷酸探针杂交、序列特异性引物聚合酶链反应以及序列分型(DNA方法)。DNA方法代表了HLA分型领域的现代趋势,很可能会取代其他大部分HLA分型技术。在我们的文章中,我们描述了用于HLA分型的方法原理。